chemagic 360 instruments in Antwerpen

chemagic 360 instruments in Antwerpen

chemagic™ 360 instruments in Antwerpen

chemagic™ 360 instruments in Belgium

Take a look at this clinical lab in Antwerpen! These four chemagic™ 360 instruments enable a Covid-19 testing capacity of up to 4000 samples/day for 7 days a week. They are part of the PerkinElmer SARS-CoV- 2 testing solution in a clinical lab in Belgium!

For research use only. Not for use in diagnostic procedures.

European Biobank Week 2020

PerkinElmer at Europe Biobank Week 2020

EBW 2020

Meet us at Europe Biobank Week 2020!

We are happy to join the European Biobank Week 2020 Conference from November 17-20 this week. Meet us on our virtual booth and talk with our experts about improving your biobanking efficiency.

 

New Technical Note cfDNA purification

Technical Note about cfDNA extraction with chemagic kits

New Technical Note cfDNA extraction

New Technical Note about high-throughput cfDNA isolation from plasma

PerkinElmer chemagen has developed the chemagic cfDNA Kits which enable the automated and efficient extraction of circulating cell-free DNA from 0.5 - 5 ml plasma in 24-well or 96-well format in maximal 2 hours with minimal hands-on time. Furthermore, the kits show equivalent yields as well as purities compared to a manual silica-spin based kit.

CE-IVD marked SARS-CoV-2 Real-Time RT-PCR

CE-IVD mark update for the PerkinElmer SARS-CoV-2 Real-time RT-PCR assay

CE-IVD mark update for SARS-CoV-2 RT-PCR assay

CE-IVD Mark Update for PerkinElmer® SARS-CoV-2 Real-Time RT-PCR Assay

The range of sample materials was upgraded, therefore the CE-IVD marked PerkinElmer® SARS-CoV-2 Real-time RT-PCR assay can be used for oropharyngeal, nasopharyngeal swabs and now for saliva samples as well. In addition, it is now possible to perform the SARS-CoV-2 detection with pooled samples of up to 5 individuals showing an acute Covid-19 infection as well as asymptomatic carriers.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Pooled samples for SARS-CoV-2 testing

Pooled samples for SARS-CoV-2 testing

FDA Emergency Use Authorization for Sample Pooling

FDA Emergency Use Authorization for Sample Pooling

PerkinElmer received the FDA EUA authorization to detect SARS-CoV-2 pathogen RNA in pooled samples containing multiple individual respiratory swabs. Furthermore, the PerkinElmer® New Coronavirus Nucleic Acid Detection Kit allows sample pooling on multiple RT-PCR platforms. While other RT-PCR kit manufacturers struggle with accurate detection due to lack of sensitivity, the PerkinElmer kit convinces by the lowest limit of detection.

For emergency use authorization only. Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.